Published in Pediatr Neurol on June 01, 2011
Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette. Eur J Neurosci (2012) 0.89
Can we safely administer the recommended dose of phenobarbital in very low birth weight infants? Childs Nerv Syst (2013) 0.80
The safety and tolerability of newer antiepileptic drugs in children and adolescents. J Cent Nerv Syst Dis (2012) 0.80
Neonatal seizures therapy: we are still looking for the efficacious drug. Ital J Pediatr (2013) 0.78
Topiramate use in the neonatal period. Pediatr Neurol (2012) 0.75
Pharmacotherapy for Seizures in Neonates with Hypoxic Ischemic Encephalopathy. Paediatr Drugs (2017) 0.75
Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord (2007) 5.59
Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci U S A (2002) 4.18
Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med (1999) 2.84
Antenatal and intrapartum risk factors for seizures in term newborns: a population-based study, California 1998-2002. J Pediatr (2008) 2.15
Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed (2007) 1.99
Neonatal seizures: multicenter variability in current treatment practices. Pediatr Neurol (2007) 1.58
The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr (1999) 1.56
Antenatal and intrapartum factors associated with the occurrence of seizures in term infant. Obstet Gynecol (1989) 1.55
Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology (2010) 1.54
Therapeutic doses of topiramate are not toxic to the developing rat brain. Exp Neurol (2004) 1.49
Characterization and classification of neonatal seizures. Neurology (1987) 1.45
Incidence of neonatal seizures in Harris County, Texas, 1992-1994. Am J Epidemiol (1999) 1.32
NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury. Epilepsia (2004) 1.23
The long-term effects of neonatal seizures. Clin Perinatol (2009) 1.19
A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology (1995) 1.18
Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke (2004) 1.16
Interobserver agreement in neonatal seizure identification. Epilepsia (2009) 1.14
Therapeutic strategies to avoid long-term adverse outcomes of neonatal antiepileptic drug exposure. Epilepsia (2010) 1.13
Predictors of 30-month outcome after perinatal depression: role of proton MRS and socioeconomic factors. Pediatr Res (2002) 1.12
Antecedents and outcome of very early neonatal seizures in infants born at or after term. Br J Obstet Gynaecol (1987) 1.10
Neonatal seizures in the United States: results of the National Hospital Discharge Survey, 1980-1991. Neuroepidemiology (1996) 1.07
Improving the treatment of neonatal seizures: National Institute of Neurological Disorders and Stroke workshop report. J Pediatr (2008) 1.06
Neonatal seizures: dilemmas in workup and management. Pediatr Neurol (2008) 1.05
Effect of topiramate following recurrent and prolonged seizures during early development. Epilepsy Res (2002) 1.01
Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res (2005) 1.00
Off-label use of antiepileptic drugs for the treatment of neonatal seizures. Pediatr Neurol (2008) 0.99
Clinical experience with open-label topiramate use in infants younger than 2 years of age. J Child Neurol (2003) 0.96
Efficacy and tolerability of topiramate in children younger than 2 years old. J Child Neurol (2005) 0.90
Topiramate loading for refractory status epilepticus in children. Epilepsia (2006) 0.89
Topiramate and adrenocorticotropic hormone (ACTH) as initial treatment for infantile spasms. J Child Neurol (2009) 0.88
Efficacy of topiramate in children with refractory status epilepticus. Epilepsia (2003) 0.87
Evaluation of open-label topiramate as primary or adjunctive therapy in infantile spasms. Clin Neuropharmacol (2008) 0.86
Topiramate monotherapy in infantile spasm. Yonsei Med J (2006) 0.84
Topiramate efficacy in an infant with partial seizures refractory to conventional antiepileptic drugs. Seizure (2004) 0.84
Efficacy and safety of topiramate in infants according to epilepsy syndromes. Seizure (2005) 0.83
Effect of topiramate on cognitive function and activity level following neonatal seizures. Epilepsy Behav (2005) 0.83
Motor performance and behavior of immature rats are not compromised by a high dose of topiramate. Epilepsy Behav (2005) 0.83
Low-dose topiramate is effective in the treatment of infantile spasms. Chang Gung Med J (2006) 0.81
Long-term effectiveness and tolerability of topiramate in children with epilepsy under the age of 2 years: 4-year follow-up. J Korean Med Sci (2009) 0.78
Screening for developmental delay in the setting of a community pediatric clinic: a prospective assessment of parent-report questionnaires. Pediatrics (2006) 2.63
Participation and enjoyment of leisure activities in school-aged children with cerebral palsy. Dev Med Child Neurol (2008) 2.18
Mutations in FLVCR1 cause posterior column ataxia and retinitis pigmentosa. Am J Hum Genet (2010) 1.72
Pediatric migraine equivalents: occurrence and clinical features in practice. Pediatr Neurol (2002) 1.62
Long-term functional benefits of selective dorsal rhizotomy for spastic cerebral palsy. J Neurosurg Pediatr (2013) 1.50
Developmental screening. J Child Neurol (2005) 1.48
Simultaneous Guillain-Barré syndrome and acute disseminated encephalomyelitis in the pediatric population. J Child Neurol (2008) 1.46
Global developmental delay and its relationship to cognitive skills. Dev Med Child Neurol (2009) 1.46
Etiologic profile of spastic quadriplegia in children. Pediatr Neurol (2007) 1.43
Acute combined central and peripheral nervous system demyelination in children. Pediatr Neurol (2008) 1.40
Predictors of developmental disabilities after open heart surgery in young children with congenital heart defects. J Pediatr (2002) 1.39
Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain (2007) 1.35
Mutations in C5ORF42 cause Joubert syndrome in the French Canadian population. Am J Hum Genet (2012) 1.32
Determinants of life quality in school-age children with cerebral palsy. J Pediatr (2007) 1.28
Mutations in TMEM231 cause Joubert syndrome in French Canadians. J Med Genet (2012) 1.23
A new look at outcomes of infants with congenital heart disease. Pediatr Neurol (2009) 1.21
Leisure activity preferences for 6- to 12-year-old children with cerebral palsy. Dev Med Child Neurol (2009) 1.19
Neurobiology of specific language impairment. J Child Neurol (2004) 1.08
Analysis of clinical features predicting etiologic yield in the assessment of global developmental delay. Pediatrics (2006) 1.07
Equivalence reliability of the Vineland Adaptive Behavior Scale between in-person and telephone administration. Phys Occup Ther Pediatr (2006) 1.06
Epileptiform abnormalities in children with attention-deficit-hyperactivity disorder. Pediatr Neurol (2002) 1.05
The thorny nature of predictive validity studies on screening tests for developmental-behavioral problems. Pediatrics (2008) 1.00
Population-based study of neuroimaging findings in children with cerebral palsy. Eur J Paediatr Neurol (2011) 0.99
Channelopathies: a review. Pediatr Neurol (2008) 0.98
Prognostic factors and development of a scoring system for outcome of neonatal seizures in term infants. Eur J Paediatr Neurol (2010) 0.98
Comorbidities and clinical determinants of outcome in children with spastic quadriplegic cerebral palsy. Dev Med Child Neurol (2008) 0.97
Motor function at school age in children with a preschool diagnosis of developmental language impairment. J Pediatr (2005) 0.97
Screening of GABRB3 in French-Canadian families with idiopathic generalized epilepsy. Epilepsia (2010) 0.94
Long-term functional outcome after selective posterior rhizotomy. J Neurosurg (2002) 0.92
Functional performance following selective posterior rhizotomy: long-term results determined using a validated evaluative measure. J Neurosurg (2002) 0.92
Determinants of participation in leisure activities among adolescents with cerebral palsy. Res Dev Disabil (2013) 0.91
Reliability in the ratings of quality of life between parents and their children of school age with cerebral palsy. Qual Life Res (2008) 0.91
Normal imaging in patients with cerebral palsy: what does it tell us? J Pediatr (2012) 0.89
The clinical spectrum of developmental language impairment in school-aged children: language, cognitive, and motor findings. Pediatrics (2006) 0.88
Child health and parental stress in school-age children with a preschool diagnosis of developmental delay. J Child Neurol (2008) 0.87
Predictors of outcome in term infants with neonatal seizures subsequent to intrapartum asphyxia. J Child Neurol (2011) 0.87
Behavioral difficulties in adolescents with cerebral palsy. J Child Neurol (2012) 0.87
Dosage effect of a dominant CLCN1 mutation: a novel syndrome. J Child Neurol (2008) 0.85
Level of motivation in mastering challenging tasks in children with cerebral palsy. Dev Med Child Neurol (2010) 0.85
Cerebral palsy, developmental delay, and epilepsy after neonatal seizures. Pediatr Neurol (2011) 0.85
Profile of pediatric hemiparesis. J Child Neurol (2005) 0.84
Clinical clues to differentiating inherited and noninherited etiologies of childhood ataxias. J Pediatr (2011) 0.84
The predictive value of a preschool diagnosis of developmental language impairment. Neurology (2004) 0.84
Behavioural problems in school age children with cerebral palsy. Eur J Paediatr Neurol (2011) 0.84
Familial retinal migraines. Pediatr Neurol (2004) 0.84
Cooling in the real world: therapeutic hypothermia in hypoxic-ischemic encephalopathy. Eur J Paediatr Neurol (2013) 0.82
Mutations in riboflavin transporter present with severe sensory loss and deafness in childhood. Muscle Nerve (2014) 0.82
Indicators of distress in families of children with cerebral palsy. Disabil Rehabil (2012) 0.82
Type I spinal muscular atrophy can mimic sensory-motor axonal neuropathy. J Child Neurol (2005) 0.82
Factors predictive of outcome in childhood epilepsy. J Child Neurol (2005) 0.82
Diagnosing Sotos syndrome in the setting of global developmental delay and macrocephaly. J Child Neurol (2006) 0.81
An instructive case of an 8-year-old boy with intellectual disability. Semin Pediatr Neurol (2008) 0.81
Neurodevelopmental disorders and genetic testing: current approaches and future advances. Ann Neurol (2013) 0.81
Spinal deformities following selective dorsal rhizotomy. J Neurosurg (2007) 0.81
The relationship between gross motor function and manual ability in cerebral palsy. J Child Neurol (2012) 0.80
Neurologic outcome at school entry for newborns treated with extracorporeal membrane oxygenation for noncardiac indications. J Child Neurol (2009) 0.80
Neurolathyrism in vapniarka: medical heroism in a concentration Camp. Can J Neurol Sci (2011) 0.80
The relationship between manual ability and ambulation in adolescents with cerebral palsy. Phys Occup Ther Pediatr (2013) 0.79
Developmental and functional abilities in children with cerebral palsy as related to pattern and level of motor function. J Child Neurol (2010) 0.79
Picture me playing-a portrait of participation and enjoyment of leisure activities in adolescents with cerebral palsy. Res Dev Disabil (2013) 0.79
Play and be happy? Leisure participation and quality of life in school-aged children with cerebral palsy. Int J Pediatr (2012) 0.79
Compound heterozygous deletions of PMP22 causing severe Charcot-Marie-Tooth disease of the Dejerine-Sottas disease phenotype. Am J Med Genet A (2008) 0.79
Ethics in neonatal neurology: when is enough, enough? Pediatr Neurol (2009) 0.78
"A cold wind coming": Heinrich Gross and child euthanasia in Vienna. J Child Neurol (2006) 0.78
DOK7 mutations presenting as a proximal myopathy in French Canadians. Neuromuscul Disord (2010) 0.78
Corrected head circumference centiles as a possible predictor of developmental performance in high-risk neonatal intensive care unit survivors. Dev Med Child Neurol (2005) 0.77
Atypical benign epilepsy of childhood with rolandic spikes: features of a subset requiring more than one medication for seizure control. J Child Neurol (2002) 0.77
Neurological and magnetic resonance imaging findings in children with developmental language impairment. J Child Neurol (2008) 0.77
Are you doing what you want to do? Leisure preferences of adolescents with cerebral palsy. Dev Neurorehabil (2013) 0.77
Pursuit of Complementary and Alternative Medicine Treatments in Adolescents With Cerebral Palsy. J Child Neurol (2013) 0.77
Exploring the neural mechanisms that underlie motor difficulties in children with Attention Deficit Hyperactivity Disorder. Dev Neurorehabil (2011) 0.77
Impact of selective posterior rhizotomy on fine motor skills. Long-term results using a validated evaluative measure. Pediatr Neurosurg (2002) 0.76
Cross-sectional comparison of periventricular leukomalacia in preterm and term children. Neurology (2010) 0.76
Treatment of pediatric status migrainosus: can we prevent the "bounce back"? J Child Neurol (2011) 0.76
A registry-based assessment of cerebral palsy and cerebral malformations. J Child Neurol (2010) 0.75
Term neonatal encephalopathy antecedent cerebral palsy: a retrospective population-based study. Eur J Paediatr Neurol (2012) 0.75
The burden of seizures in children. Can J Neurol Sci (2004) 0.75
Predicting comorbidities with neuroimaging in children with cerebral palsy. Pediatr Neurol (2011) 0.75
The challenge of Canadian pediatric neurology manpower supply. Can J Neurol Sci (2005) 0.75
Does antenatal tobacco or alcohol exposure influence a child's cerebral palsy? A population-based study. Pediatr Neurol (2012) 0.75
Pediatric meralgia paresthetica. Pediatr Neurol (2002) 0.75
Communicating a diagnosis of cerebral palsy: caregiver satisfaction and stress. Pediatr Neurol (2006) 0.75
A novel chronic childhood sensory predominant neuropathy. Pediatr Neurol (2002) 0.75
Abnormal myelination in ring chromosome 18 syndrome. J Child Neurol (2012) 0.75
A clinical and etiologic profile of spastic diplegia. Pediatr Neurol (2006) 0.75
Stability of motor impairment in children with cerebral palsy. Dev Med Child Neurol (2007) 0.75
Does ketamine affect intraoperative electrophysiological monitoring in children undergoing selective posterior rhizotomy? Paediatr Anaesth (2008) 0.75
Features of a subset of children with complex partial epilepsy requiring combination therapy for effective seizure control. J Child Neurol (2009) 0.75
Updates in the treatment of spasticity associated with cerebral palsy. Curr Treat Options Neurol (2012) 0.75